Andrew Jackson - Chief Financial Officer at Calidi Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CLDI on NYSE, CLDWW on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Andrew Jackson - trading volume in the past year for Calidi Biotherapeutics, Inc.

Holdings reported by Andrew Jackson for Calidi Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.5K $5K $2.00 Aug 21, 2025 Direct
Stock Options (right to buy) 30K Sep 3, 2025 Direct Common stock
Warrant (right to buy) 2.5K Aug 21, 2025 Direct Common stock

Transactions reported by Andrew Jackson for Calidi Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.